DK8189A - Antigen-antistof-konjugater, deres fremstilling og anvendelse - Google Patents
Antigen-antistof-konjugater, deres fremstilling og anvendelseInfo
- Publication number
- DK8189A DK8189A DK008189A DK8189A DK8189A DK 8189 A DK8189 A DK 8189A DK 008189 A DK008189 A DK 008189A DK 8189 A DK8189 A DK 8189A DK 8189 A DK8189 A DK 8189A
- Authority
- DK
- Denmark
- Prior art keywords
- antigen
- preparation
- antibody conjugates
- conjugates
- antibody
- Prior art date
Links
- 229940127121 immunoconjugate Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6849—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6056—Antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/819—Multifunctional antigen or antibody
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPI625688 | 1988-01-12 | ||
| AUPI747088 | 1988-03-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK8189D0 DK8189D0 (da) | 1989-01-10 |
| DK8189A true DK8189A (da) | 1989-07-13 |
Family
ID=25643407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK008189A DK8189A (da) | 1988-01-12 | 1989-01-10 | Antigen-antistof-konjugater, deres fremstilling og anvendelse |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5204449A (da) |
| EP (1) | EP0324625A1 (da) |
| JP (1) | JPH02153000A (da) |
| KR (1) | KR890011608A (da) |
| CN (1) | CN1034581A (da) |
| AU (1) | AU619239B2 (da) |
| DK (1) | DK8189A (da) |
| MY (1) | MY104946A (da) |
| NO (1) | NO890115L (da) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3813023A1 (de) * | 1988-04-19 | 1989-11-16 | Behringwerke Ag | Monoklonaler antikoerper gegen pseudomonas aeruginosa, seine herstellung und verwendung |
| GB8907310D0 (en) * | 1989-03-31 | 1989-05-17 | Medical Res Council | Heteroconjugates |
| US6329508B1 (en) | 1989-09-07 | 2001-12-11 | Alkermes, Inc. | Transferrin receptor reactive chimeric antibodies |
| US5977307A (en) * | 1989-09-07 | 1999-11-02 | Alkermes, Inc. | Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins |
| US5527527A (en) * | 1989-09-07 | 1996-06-18 | Alkermes, Inc. | Transferrin receptor specific antibody-neuropharmaceutical agent conjugates |
| US5154924A (en) * | 1989-09-07 | 1992-10-13 | Alkermes, Inc. | Transferrin receptor specific antibody-neuropharmaceutical agent conjugates |
| US5672683A (en) * | 1989-09-07 | 1997-09-30 | Alkermes, Inc. | Transferrin neuropharmaceutical agent fusion protein |
| US5182107A (en) * | 1989-09-07 | 1993-01-26 | Alkermes, Inc. | Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates |
| US6165465A (en) * | 1990-05-15 | 2000-12-26 | American Cyanamid Company | Immunologic enhancement of the somatogenic effect of somatotropin with an antibody |
| AU648140B2 (en) * | 1991-02-01 | 1994-04-14 | Virtual Drug Development, Inc. | Reverse antimicrobial peptides and antimicrobial compositions |
| JP3105629B2 (ja) * | 1991-04-23 | 2000-11-06 | サングスタット メディカル コーポレイション | 特異的結合ペアのメンバーの細胞活性調節接合体 |
| AU634379B2 (en) * | 1991-04-29 | 1993-02-18 | Csl Limited | Recombinant immunocastration vaccine |
| JPH0795418A (ja) * | 1993-09-20 | 1995-04-07 | Canon Inc | 画像通信装置 |
| US7354587B1 (en) | 1994-07-06 | 2008-04-08 | Immunomedics, Inc. | Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
| CN1127352C (zh) * | 1994-08-05 | 2003-11-12 | 威斯康星校友研究基金会 | 用于改善饲料效率的肠促胰酶肽抗体 |
| US5698679A (en) * | 1994-09-19 | 1997-12-16 | National Jewish Center For Immunology And Respiratory Medicine | Product and process for targeting an immune response |
| US6015555A (en) * | 1995-05-19 | 2000-01-18 | Alkermes, Inc. | Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates |
| DE19548028A1 (de) * | 1995-12-21 | 1997-06-26 | Bayer Ag | Verfahren zur Herstellung eines synthetischen Kalibrators für den Einsatz in Sandwich-Immunoassays, bestehend aus einem Antikörper gegen einen der im Assay benutzten Antikörper und einer Sequenz des Analyten |
| JP2000503003A (ja) * | 1995-12-22 | 2000-03-14 | イムノメディクス，インコーポレイテッド | 多段階カスケード増強ワクチンの効果を高めるための免疫接合体の使用 |
| US6060054A (en) | 1996-04-10 | 2000-05-09 | National Jewish Medical And Research Center | Product for T lymphocyte immunosuppression |
| ES2210514T3 (es) * | 1996-04-10 | 2004-07-01 | Sangstat Medical Corporation | Conjugados citomoduladores de miembros de pares de union especificos. |
| WO2000000156A2 (en) * | 1998-06-26 | 2000-01-06 | Trustees Of Dartmouth College | Methods for modulating immunological responses by targeting antigen to apcs in conjuction with anti-cd40 ligands |
| US6926146B2 (en) * | 1999-10-12 | 2005-08-09 | Joseph A. Gheblikian | Small component parts filing and inventory control system |
| US7645743B2 (en) * | 1999-12-22 | 2010-01-12 | Altermune, Llc | Chemically programmable immunity |
| CA2328356A1 (en) * | 1999-12-22 | 2001-06-22 | Itty Atcravi | Recreational vehicles |
| KR100863632B1 (ko) | 2000-03-31 | 2008-10-15 | 퍼듀 리서치 파운데이션 | 리간드-면역원 접합체를 사용한 치료 방법 |
| US8562988B2 (en) | 2005-10-19 | 2013-10-22 | Ibc Pharmaceuticals, Inc. | Strategies for improved cancer vaccines |
| US8551480B2 (en) | 2004-02-13 | 2013-10-08 | Immunomedics, Inc. | Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity |
| US9481878B2 (en) | 2004-02-13 | 2016-11-01 | Immunomedics, Inc. | Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity |
| US8652484B2 (en) | 2004-02-13 | 2014-02-18 | Immunomedics, Inc. | Delivery system for cytotoxic drugs by bispecific antibody pretargeting |
| US8435539B2 (en) | 2004-02-13 | 2013-05-07 | Immunomedics, Inc. | Delivery system for cytotoxic drugs by bispecific antibody pretargeting |
| US7985783B2 (en) | 2006-09-21 | 2011-07-26 | The Regents Of The University Of California | Aldehyde tags, uses thereof in site-specific protein modification |
| US8729232B2 (en) * | 2008-03-27 | 2014-05-20 | The Regents Of The University Of California | Aldehyde tags, uses thereof in site-specific protein modification |
| RU2539765C2 (ru) | 2008-07-16 | 2015-01-27 | Бейлор Рисёч Инститьют | ВИЧ ВАКЦИНА, ОСНОВАННАЯ НА НАПРАВЛЕННОСТИ МАКСИМИЗИРОВАННЫХ Gag И Nef НА ДЕНДРИТНЫЕ КЛЕТКИ |
| AU2009282830B2 (en) | 2008-08-20 | 2013-11-28 | Ibc Pharmaceuticals, Inc. | Dock-and-lock (DNL) vaccines for cancer therapy |
| US9238878B2 (en) * | 2009-02-17 | 2016-01-19 | Redwood Bioscience, Inc. | Aldehyde-tagged protein-based drug carriers and methods of use |
| BRPI1011269A2 (pt) | 2009-05-05 | 2016-09-27 | Altermune Technologies Llc | imunidade quimicamente programável |
| JP6855496B2 (ja) | 2015-11-09 | 2021-04-07 | アール．ピー．シェーラー テクノロジーズ エルエルシー | 抗ｃｄ２２抗体−メイタンシンコンジュゲートおよびその使用方法 |
| KR20180135458A (ko) | 2016-04-26 | 2018-12-20 | 알.피.쉐러 테크놀러지즈 엘엘씨 | 항체 컨쥬게이트 및 이의 제조 및 이용 방법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5059524A (en) * | 1986-02-26 | 1991-10-22 | The University Of Melbourne | Hla-b27 testing |
| GB8610983D0 (en) * | 1986-05-06 | 1986-06-11 | Connaught Lab | Enhancement of antigen immunogenicity |
| CA1330378C (en) * | 1986-05-08 | 1994-06-21 | Daniel J. Coughlin | Amine derivatives of folic acid analogs |
-
1989
- 1989-01-10 DK DK008189A patent/DK8189A/da not_active Application Discontinuation
- 1989-01-11 CN CN89100263A patent/CN1034581A/zh active Pending
- 1989-01-11 US US07/296,229 patent/US5204449A/en not_active Expired - Fee Related
- 1989-01-11 NO NO89890115A patent/NO890115L/no unknown
- 1989-01-12 MY MYPI89000041A patent/MY104946A/en unknown
- 1989-01-12 JP JP1005837A patent/JPH02153000A/ja active Pending
- 1989-01-12 EP EP89300279A patent/EP0324625A1/en not_active Withdrawn
- 1989-01-12 KR KR1019890000267A patent/KR890011608A/ko not_active Withdrawn
- 1989-01-12 AU AU28438/89A patent/AU619239B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CN1034581A (zh) | 1989-08-09 |
| AU2843889A (en) | 1989-07-13 |
| US5204449A (en) | 1993-04-20 |
| NO890115D0 (no) | 1989-01-11 |
| DK8189D0 (da) | 1989-01-10 |
| AU619239B2 (en) | 1992-01-23 |
| MY104946A (en) | 1994-07-30 |
| JPH02153000A (ja) | 1990-06-12 |
| NO890115L (no) | 1989-07-13 |
| EP0324625A1 (en) | 1989-07-19 |
| KR890011608A (ko) | 1989-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK8189D0 (da) | Antigen-antistof-konjugater, deres fremstilling og anvendelse | |
| DK374389A (da) | Arylbenzenoxazolidinoner, deres fremstilling og anvendelse | |
| DK609489A (da) | Imidazolderivater, deres fremstilling og anvendelse | |
| NO900469L (no) | Piperidinforbindelser, deres fremstilling og anvendelse. | |
| DK388989A (da) | Acylcyanoguanidiner, deres fremstilling og anvendelse | |
| NO895030L (no) | 2-imino-benzotiazolinderivater og deres fremstilling. | |
| DK371088D0 (da) | Azacykliske forbindelser, deres fremstilling og anvendelse | |
| DK435289A (da) | Piperazindioner, deres fremstilling og anvendelse | |
| NO903096L (no) | Termotrope semialifatiske kopolyesteramider og deres fremstilling. | |
| DK225089A (da) | 2-adamantyl-4-isothiazolin-3-oner, deres fremstilling og anvendelse | |
| DK8589D0 (da) | Pyrazol- og indazolpyridinaminer, deres fremstilling og anvendelse | |
| DK469389D0 (da) | Piperidinyl-imidazol-derivater, deres fremstilling og anvendelse | |
| DK641989D0 (da) | Bis-arylphosphatestere, deres fremstilling og anvendelse | |
| DK189488D0 (da) | Imidazothiadiazinderivater, deres fremstilling og anvendelse | |
| DK162087D0 (da) | Piperidinforbindelser, deres fremstilling og anvendelse | |
| DK592389D0 (da) | Penemderivater, deres fremstilling og anvendelse | |
| DK185489A (da) | Imidazolylmethyl-cycloalkanoebaaindoloner, deres fremstilling og anvendelse | |
| NO894821D0 (no) | Homopolysakkarid, opploesning derav, og deres fremstillingog anvendelse. | |
| DK455189D0 (da) | 2,3,4,5-tetrahydro-1-benzoxepiner, deres fremstilling og anvendelse | |
| DK82589A (da) | Piperidinforbindelser, deres fremstilling og anvendelse | |
| DK163589D0 (da) | Sakyomycin e og derivater deraf, deres fremstilling og anvendelse | |
| DK297188D0 (da) | Imidazoquinoxalinforbindelser, deres fremstilling og anvendelse | |
| DK142288D0 (da) | Quinoxalinforbindelser, deres fremstilling og anvendelse | |
| DK258289D0 (da) | Imidazoquinoxalin forbindelser, deres fremstilling og anvendelse | |
| DK625988D0 (da) | Imidazoquinoxalinforbindelser, deres fremstilling og anvendelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment | ||
| AHS | Application shelved for other reasons than non-payment |